Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

December 31, 2028

Conditions
HIV-1-infectionMulti-Antiviral Resistance
Interventions
OTHER

REGISTER CREATION

Build a national registry of patients with HIV-1 infection and documented resistance to the 4 classes of antiretroviral drugs.

Trial Locations (1)

20127

RECRUITING

Ospedale San Raffaele, Milan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ViiV Healthcare

INDUSTRY

lead

Castagna Antonella

OTHER